A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies

CONCLUSIONS:  HARC was well tolerated and non-inferior to Control for correction of midface fullness at 12 weeks after last injection. Aesthetic improvement and subject satisfaction were high and lasted through week 48.  J Drugs Dermatol. 2021;20(9):949-956. doi:10.36849/JDD.6191.PMID:34491026 | DOI:10.36849/jdd.6191

Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Derek Jones Leslie Baumann Amir Moradi Sachin Shridharani Melanie Palm Craig Teller Mark Taylor Theda C Kontis Anne Chapas Michael S Kaminer David Bank Kenneth Beer Deirdre Hooper Source Type: research